《新股表現》經緯天地(02477.HK)首日掛牌 開市較上市價高77%
經緯天地(02477.HK)首日掛牌,開市報1.77元,較上市價1元,高77%,市前成交735萬股。
經緯天地是中國電信網絡支援、以及信息和通信技術(ICT)集成服務供應商及軟件開發商。是次上市共發售1.25億股,其中10%公開發售獲近28倍超購,已啟動回撥機制佔比增至20%,認購一手中籤率20%;股份以招股範圍(1-1.3元)下限定價,料集資淨額6,267萬元,主要用於未來ICT集成項目提供資金滿足初始資金需求、開展新研發項目、壯大項目管理團隊以配合預期擴充計劃和業務增長,以及還債等。上市聯席保薦人分別為鎧盛及艾德金融。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.